Delpharm is a leading CDMO :
– 17 plants in France, Italy, Canada, Poland and The Netherlands
– Over 950 million euros turnover
– 6,000 people working in the company
– Most dosage forms produced
Over the last 30 years, the men and women of Delpharm have built a strong reputation of experienced professionals, supplying a wide range of most demanding customers. They are all committed to listen, be transparent and available, in order to make their customers benefit from their know how, acquired throught to the diversity of teams and experiences. The whole diversity of customers and succesfull projects over the past years have helped Delpharm to grow even more and gain in efficiency. This is all benefit in order to serve more and more customers.
cmo, pharmaceutical drug, solid form, liquid form, semi solid form, cdmo, hormone, oncology, sterile, serializatiuon, serialisation, fabrication medicament, fda, pmda, anvisa, drug manufacturing, drug plant, drug development, softgel, regulatory